E
Aspira Women's Health Inc. AWHL
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 21.55% 18.67% 24.99% 45.80% 44.15%
Total Depreciation and Amortization -53.77% -50.22% -48.84% -41.48% -24.62%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -48.39% -205.16% 160.54% -91.09% -72.49%
Change in Net Operating Assets 209.78% 141.35% 117.94% 80.43% 108.04%
Cash from Operations 23.79% 25.50% 36.99% 45.04% 48.84%
Capital Expenditure -54.17% 43.02% 66.19% 77.22% 89.66%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -54.17% 43.02% 66.19% 77.22% 89.66%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 37.16% 83.57% 100.67% 77.01% 43.30%
Issuance of Common Stock 68.63% 103.55% 36.24% 29.68% -32.38%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 220.25% 242.66% 8.84% 11.26% 44.83%
Cash from Financing 112.12% 173.20% 50.20% 41.63% -29.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 89.85% 79.13% 78.19% 78.70% 55.17%